SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Advances in RA treatment require improved understanding of patient-specific therapy appropriateness, focusing on disease pathogenesis and heterogeneity. Current RA treatment algorithms lack biomarkers ...

Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...

Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

Dr. Beth Jonas answers the question: 'Anti-TNF Meds For Rheumatoid Arthritis?' — -- Question: What are anti-tumor necrosis factor (anti-TNF) medications and how are they used to treat rheumatoid ...

The results of research by scientists at Trinity College Dublin and St. Vincent’s University Hospital offer new insights into the cellular and genetic features of joint inflammation in rheumatoid ...

Rheumatoid arthritis affects millions of Americans, gradually changing lives as it progresses from subtle joint discomfort to potentially severe mobility limitations. For those living with this ...

Novel “RA Response Calculator” Uses AI and Real Patient Data to Help Doctors Better Tailor Treatment Plans At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind ...

Medically reviewed by Stella Bard, MD Osteoarthritis occurs when joint cartilage breaks down over time, causing pain and stiffness.Rheumatoid arthritis is an autoimmune disease where the immune system ...

Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...

Despite the rising incidence of rheumatoid arthritis (RA), extra-articular manifestations have become rare in the era of modern treat-to-target therapy. However, they still present clinical challenges ...